small molecule

CAPECITABINE

CAPECITABINE

Loss of exclusivity—loss of exclusivity
CompanyShilpa Medicare →See this company's full patent-cliff portfolio

Drug detail

Brand nameCAPECITABINE
Active ingredientCAPECITABINE
Strength150MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalDecember 2016
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.